6926 - 6950 of 8808 Results
Title
Year
-
OPENTitle: Novel recruitment strategy to enrich forLRRK2mutation carriersJournal Name: Molecular Genetics & Genomic MedicinePublisher: WileyVol: 3Issue #: 5Start Page: 404End Page: 412Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mgg3.151Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mgg3.151Citation Count: 18
-
OPENTitle: Cortical structural involvement and cognitive dysfunction in early Parkinson's diseaseJournal Name: NMR in BiomedicinePublisher: WileyVol: 31Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/nbm.3900Citation Count: 8
-
OPENTitle: Lack of Antiparkinsonian Effects of Systemic Injections of the Specific T-Type Calcium Channel Blocker ML218 in MPTP-Treated MonkeysJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 7Issue #: 11Start Page: 1543End Page: 1551Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.6b00186Best OA location URL: http://doi.org/10.1021/acschemneuro.6b00186Citation Count: 9
-
OPENTitle: The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and humanJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 475Issue #: 11Start Page: 1861End Page: 1883Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1042/bcj20180248Best OA location URL: https://portlandpress.com/biochemj/article-pdf/475/11/1861/691623/bcj-2018-0248.pdfCitation Count: 199
-
OPENTitle: Blood–brain barrier permeability in Parkinson’s disease patients with and without dyskinesiaJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 268Issue #: 6Start Page: 2246End Page: 2255Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00415-021-10411-1Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11197155Citation Count: 12
-
OPENTitle: Rotigotine in the Long-Term Treatment of Severe RLS with Augmentation: A Series of 28 CasesJournal Name: Sleep DisordersPublisher: WileyVol: 2011Issue #:Start Page: 1End Page: 6Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2011/468952Best OA location URL: https://downloads.hindawi.com/journals/sd/2011/468952.pdfCitation Count: 9
-
OPENTitle: Phosphoproteomic evaluation of pharmacological inhibition of leucine‐rich repeat kinase 2 reveals significant off‐target effects of LRRK‐2‐IN‐1Journal Name: Journal of NeurochemistryPublisher: WileyVol: 128Issue #: 4Start Page: 561End Page: 576Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.12483Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.12483Citation Count: 63
-
OPENTitle: Quantifying regional α ‐synuclein, amyloid β, and tau accumulation in lewy body dementiaJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 9Issue #: 2Start Page: 106End Page: 121Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.51482Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.51482Citation Count: 35
-
OPENTitle: LRRK2 inhibition does not impart protection from α-synuclein pathology and neuron death in non-transgenic miceJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-019-0679-5Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-019-0679-5Citation Count: 45
-
OPENTitle: Modelling idiopathic Parkinson disease as a complex illness can inform incidence rate in healthy adults: the PREDIGT scoreJournal Name: European Journal of NeurosciencePublisher: WileyVol: 45Issue #: 1Start Page: 175End Page: 191Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1111/ejn.13476Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ejn.13476Citation Count: 24
-
OPENTitle: Cardiac sympathetic denervation and synucleinopathy in Alzheimer’s disease with brain Lewy body diseaseJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 2Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcaa004Best OA location URL: https://academic.oup.com/braincomms/article-pdf/2/1/fcaa004/33639616/fcaa004.pdfCitation Count: 10
-
OPENTitle: In Silico and In Vitro Study towards the Rational Design of 4,4′-Disarylbisthiazoles as a Selective α-Synucleinopathy BiomarkerJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 24Issue #: 22Start Page: 16445End Page: 16445Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms242216445Best OA location URL: https://www.mdpi.com/1422-0067/24/22/16445/pdf?version=1700208971Citation Count: 4
-
OPENTitle: Mesocorticolimbic dopaminergic innervation modulates Levodopa-related improvements in gait in older slow walking Adults: A [11C]PE2I PET studyJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 12Issue #:Start Page: 100353End Page: 100353Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.prdoa.2025.100353Best OA location URL: https://doi.org/10.1016/j.prdoa.2025.100353Citation Count: 1
-
OPENTitle: CoREST Complex-Selective Histone Deacetylase Inhibitors Show Prosynaptic Effects and an Improved Safety Profile To Enable Treatment of SynaptopathiesJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 10Issue #: 3Start Page: 1729End Page: 1743Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.8b00620Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6429430Citation Count: 42
-
OPENTitle: Unveiling a novel memory center in human brain: neurochemical identification of the nucleus incertus, a key pontine locus implicated in stress and neuropathologyJournal Name: Biological ResearchPublisher: Springer Science and Business Media LLCVol: 57Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40659-024-00523-zBest OA location URL: https://biolres.biomedcentral.com/counter/pdf/10.1186/s40659-024-00523-zCitation Count: 2
-
OPENTitle: An artificial intelligence-derived metabolic network predicts psychosis in Alzheimer’s diseaseJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 7Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcaf159Best OA location URL: https://doi.org/10.1093/braincomms/fcaf159Citation Count: 0
-
OPENTitle: Development of a Novel Electrochemiluminescence ELISA for Quantification of α-Synuclein Phosphorylated at Ser129 in Biological SamplesJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 14Issue #: 7Start Page: 1238End Page: 1248Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschemneuro.2c00676Best OA location URL: https://escholarship.org/uc/item/0042q8vmCitation Count: 24
-
RESTRICTEDTitle: Wearables for Parkinson's: Fast‐Paced toward Novel Outcome MeasuresJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 11Start Page: 1988End Page: 1989Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29608Citation Count: 1
-
OPENTitle: Loss of FBXO7 (PARK15) results in reduced proteasome activity and models a parkinsonism‐like phenotype in miceJournal Name: The EMBO JournalPublisher: Springer Science and Business Media LLCVol: 35Issue #: 18Start Page: 2008End Page: 2025Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.15252/embj.201593585Best OA location URL: http://hdl.handle.net/11858/00-001M-0000-002C-0F1C-BCitation Count: 64
-
OPENTitle: Generation of two induced pluripotent stem cell lines and the corresponding isogenic controls from Parkinson’s disease patients carrying the heterozygous mutations c.1290A > G (p.T351A) or c.2067A > G (p.T610A) in the RHOT1 gene encoding Miro1Journal Name: Stem Cell ResearchPublisher: Elsevier BVVol: 69Issue #:Start Page: 103085End Page: 103085Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.scr.2023.103085Best OA location URL: https://doi.org/10.1016/j.scr.2023.103085Citation Count: 1
-
OPENTitle: Population‐specific frequencies for LRRK2 susceptibility variants in the genetic epidemiology of Parkinson's disease (GEO‐PD) consortiumJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 12Start Page: 1740End Page: 1744Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25600Best OA location URL: http://doi.org/10.1002/mds.25600Citation Count: 34
-
OPENTitle: Subcellular and regional localization of mRNA translation in midbrain dopamine neuronsJournal Name: Cell ReportsPublisher: Elsevier BVVol: 38Issue #: 2Start Page: 110208End Page: 110208Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.celrep.2021.110208Best OA location URL: http://www.cell.com/article/S2211124721017125/pdfCitation Count: 46
-
OPENTitle: Parkinson's disease relevant pathological features are manifested in male Pink1/Parkin deficient ratsJournal Name: Brain, Behavior, & Immunity - HealthPublisher: Elsevier BVVol: 31Issue #:Start Page: 100656End Page: 100656Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bbih.2023.100656Best OA location URL: https://doi.org/10.1016/j.bbih.2023.100656Citation Count: 7
- Evaluation of the Braak staging scheme for Parkinson's disease: Introduction to a panel presentation2010RESTRICTEDTitle: Evaluation of the Braak staging scheme for Parkinson's disease: Introduction to a panel presentationJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: S1Start Page: S76End Page: 7Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.22783Citation Count: 21
-
OPENTitle: The effect of LRRK2 loss-of-function variants in humansJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 26Issue #: 6Start Page: 869End Page: 877Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41591-020-0893-5Best OA location URL: https://www.nature.com/articles/s41591-020-0893-5.pdfCitation Count: 103